Company news
Cytosorbents Corporation (NASDAQ:CTSO) news
Every Cytosorbents Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights
July 20, 2026
CytoSorbents to Present at the Life Sciences Forum on June 24, 2026 and Meet Virtually with Investors on June 30, 2026
June 18, 2026
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
May 13, 2026
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights
April 30, 2026
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
March 25, 2026
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
March 19, 2026
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
March 5, 2026
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
January 12, 2026
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
December 10, 2025
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
November 17, 2025
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
November 13, 2025
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
November 11, 2025
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
October 30, 2025
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief M...
October 28, 2025
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
September 29, 2025
CytoSorbents Provides DrugSorb-ATR Regulatory Update
September 16, 2025
CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of...
September 8, 2025
CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 5, 2025
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
August 20, 2025
CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update
August 7, 2025
CytoSorbents Leads a New Era in Sepsis Treatment
July 31, 2025
CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights
July 29, 2025
CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR
July 2, 2025
CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR
June 24, 2025
CytoSorbents to Participate at the Jefferies Global Healthcare Conference
May 29, 2025
CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025
May 22, 2025
CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
CytoSorbents Provides Regulatory Update for DrugSorb-ATR
May 1, 2025
CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights
April 29, 2025
CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program
April 21, 2025
CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller
April 17, 2025
CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America
April 14, 2025
CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants
April 4, 2025
CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
March 31, 2025
CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit
March 21, 2025
CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller
March 4, 2025
CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
February 26, 2025
CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants
February 25, 2025
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering
January 13, 2025
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai
January 6, 2025
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue
January 3, 2025
CytoSorbents Rights Offering Begins
December 23, 2024
CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
December 12, 2024
CytoSorbents Announces Rights Offering
December 9, 2024
CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference
November 26, 2024
CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India
November 11, 2024
CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
November 7, 2024
CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
November 4, 2024
FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive ...
October 22, 2024
CytoSorbents to Report Third Quarter 2024 Operating and Financial Results
October 17, 2024